European Stocks Falter Amid US Med-Tech Investigation

European stocks saw declines as med-tech shares dropped following U.S. import probes. The STOXX 600 index fell, with healthcare leading losses. However, gains in H&M boosted the market sentiment slightly. Central bank policy signals and economic data continue to drive investor sentiment and outlook.


Devdiscourse News Desk | Updated: 25-09-2025 22:14 IST | Created: 25-09-2025 22:14 IST
European Stocks Falter Amid US Med-Tech Investigation
This image is AI-generated and does not depict any real-life event or location. It is a fictional representation created for illustrative purposes only.

European stocks took a hit on Thursday, primarily driven down by losses in the med-tech sector. This comes as the U.S. initiated new import investigations focusing on national security concerns, impacting shares like Siemens Healthineers and Philips.

While healthcare stocks were the hardest hit, with a notable 1.9% decline, other sectors such as construction and industrial goods also saw downturns. Meanwhile, H&M provided a glimmer of hope, rising nearly 10% due to a strong profit report.

Economic indicators and central bank stances remain the focal points for investors. The Federal Reserve's cautious rate policy and upcoming inflation reports could significantly shape market moves in the coming weeks.

(With inputs from agencies.)

Give Feedback